NIH-funded research R01 grant

Creating a 3D-printed artificial cornea to restore vision

Official title: 3D bioprinting of a bilayered, tissue engineered cornea

Funded at Stanford University · NIH-11001162 · Data updated 2026-11-12

This study is working on a new 3D-printed artificial cornea to help people with corneal blindness see better, offering a solution that doesn't depend on donor tissue and can be made whenever it's needed.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2027
Funding year2025
Award (this year)$532,313
NIH project number5R01EY035697-02
Project IDNIH-11001162 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with corneal blindness who are unable to receive traditional corneal transplants due to donor tissue shortages.

Less likely to help

Patients with corneal blindness who are not suitable candidates for any form of corneal transplantation may not benefit from this research.

What this research studies

This research focuses on developing a 3D-printed, bilayered artificial cornea to address corneal blindness, which affects millions globally. By utilizing advanced bioprinting techniques, the team aims to create a cornea that mimics the natural structure and function of human tissue, incorporating specialized biomaterials and stem cells to enhance healing and transparency. The project seeks to overcome the limitations of current corneal transplants, which rely on scarce donor tissue, by providing a viable alternative that can be produced on demand. Patients may benefit from improved access to sight-restoring treatments without the need for donor tissue.

Why it matters

Potential benefit: If successful, this research could provide a new, accessible treatment option for patients suffering from corneal blindness.

How similar studies have gone: While the approach of 3D bioprinting for tissue engineering is relatively novel, there have been promising advancements in similar fields, indicating potential for success.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Heilshorn, Sarah C — Stanford University
  • Study coordinator: Heilshorn, Sarah C

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.